These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35189)

  • 21. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketazolam and diazepam in anxiety: a controlled study.
    Rickels K; Csanalosi I; Greisman P; Mirman MJ; Morris RJ; Weise CC; Weiss G
    J Clin Pharmacol; 1980 Oct; 20(10):581-9. PubMed ID: 6108335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of clobazam and lorazepam on the psychomotor performance of anxious patients.
    Oblowitz H; Robins AH
    Br J Clin Pharmacol; 1983 Jul; 16(1):95-9. PubMed ID: 6136292
    [No Abstract]   [Full Text] [Related]  

  • 24. Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety.
    Magnus RV; Dean BC; Curry SH
    Dis Nerv Syst; 1977 Oct; 38(10):819-21. PubMed ID: 20284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
    Frattola L; Piolti R; Bassi S; Albizzati MG; Cesana BM; Bottani MS; Priore P; Borghi C; Morselli PL
    Clin Neuropharmacol; 1992 Dec; 15(6):477-87. PubMed ID: 1362137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the effect of two benzodiazepines in the treatment of anxious outpatients.
    de Figueiredo R; Franchini A; Martinho A; Hindmarch I
    Int Pharmacopsychiatry; 1981; 16(1):57-65. PubMed ID: 6117537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.
    Hindmarch I; Parrott AC
    Br J Clin Pharmacol; 1979 Oct; 8(4):325-9. PubMed ID: 41548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and experimental comparison of diazepam, chlorazepate and placebo.
    Dureman I; Norrman B
    Psychopharmacologia; 1975; 40(4):279-84. PubMed ID: 238256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients.
    Fabre LF; McLendon DM; Mallette A
    J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the psychotropic profiles of tofisopam and diazepam.
    Bond A; Lader M
    Eur J Clin Pharmacol; 1982; 22(2):137-42. PubMed ID: 6124424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind study of clobazam (Odipam) and diazepam in non-psychotic anxiety states].
    Ostrogonac S; Vuckovic S
    Med Pregl; 1989; 42(1-2):19-21. PubMed ID: 2569665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clobazam. A 1.5 benzodiazepine derivative: effects upon human psychomotor performance under different levels of task reinforcement.
    Parrott AC; Hindmarch I
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):261-8. PubMed ID: 28096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical study of clobazam in patients with gastrointestinal disorders [proceedings].
    Laudano O
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):129S. PubMed ID: 35193
    [No Abstract]   [Full Text] [Related]  

  • 40. Personal constructs of anxiety under the 1,5-benzodiazepine derivative clobazam related to trait-anxiety levels of the personality.
    Parrott AC; Kentridge R
    Psychopharmacology (Berl); 1982; 78(4):353-7. PubMed ID: 6130558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.